Integer ITGR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Integer (ITGR) Core Market Data and Business Metrics
Latest Closing Price
$118.56Price-Earnings Ratio
35.29Total Outstanding Shares
33.62 Million SharesDividend
No dividendSIC Description
Electromedical & Electrotherapeutic ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
5830 Granite Parkway., Suite 1150, Plano, TX, 75024
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
---|---|---|---|
730,909 Shares | 3.64 | 3/14/2025 | 2,659,187 Shares |
487,788 Shares | 4.55 | 2/28/2025 | 2,219,325 Shares |
235,786 Shares | 9 | 2/14/2025 | 2,122,472 Shares |
229,376 Shares | 9.31 | 1/31/2025 | 2,134,800 Shares |
169,629 Shares | 13.41 | 1/15/2025 | 2,275,224 Shares |
174,621 Shares | 12.51 | 12/31/2024 | 2,183,769 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities | $13.32 Million |
Net Cash Flow From Operating Activities | $205.21 Million |
Net Cash Flow From Operating Activities, Continuing | $205.21 Million |
Net Cash Flow | $22.87 Million |
Exchange Gains/Losses | $-243,000 |
Net Cash Flow From Investing Activities | $-195.41 Million |
Income Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Income/Loss From Continuing Operations After Tax | $121.05 Million |
Operating Expenses | $250.78 Million |
Income Tax Expense/Benefit | $26.51 Million |
Net Income/Loss Available To Common Stockholders, Basic | $119.90 Million |
Diluted Average Shares | $35.65 Million |
Cost Of Revenue | $1.26 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Other Comprehensive Income/Loss | $-34.27 Million |
Comprehensive Income/Loss | $85.63 Million |
Comprehensive Income/Loss Attributable To Parent | $85.63 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Equity Attributable To Parent | $1.62 Billion |
Other Non-current Assets | $1.16 Billion |
Assets | $3.08 Billion |
Other Current Assets | $423.99 Million |
Liabilities | $1.46 Billion |
Equity Attributable To Noncontrolling Interest | $0 |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |